We are dedicated to supporting the development of life-saving vaccines. We offer comprehensive clinical trial services to vaccine companies and we understand the critical role vaccines play in global health. Our team of experienced clinical trial associate, managers and vaccine experts has a deep understanding of the unique challenges and complexities involved in vaccine Clinical Trials. Our unwavering commitment to quality and compliance ensures that your vaccine clinical trials meet all regulatory standards and adhere to best practices. We have a proven track record of successfully working on many vaccine candidates those are already in the market now.
You can see below some of the vaccine where we have work in recent time. Let us know how we can contribute in your biosimilar clinical development program.
| Sr.No | Type Of vaccine | Phase of Trial | Study Population | No of Sites |
|---|---|---|---|---|
| 1 | Liquid Hexavalent | Phase I | 48 | 1 |
| 2 | Japanese Encephalitis & Measles Mumps & Rubella | Phase III | 570 | 9 |
| 3 | Hepatitis B | PMS | 500 | 7 |
| 4 | Dengue | Phase I | 90 | 2 |
| 5 | Measles Mumps & Rubella Vaccine | Phase II/III | 888 | 6 |
| 6 | Hepatitis A | Phase II/III | 528 | 8 |
| 7 | TT Vaccine | Phase I | 40 | 1 |
| 8 | TT Vaccine | Phase II/III | 180 | 4 |
| 9 | Td Vaccine | Phase II/III | 120 | 4 |
| 10 | Covid-19 | Phase III | 360 | 8 |
| 11 | Chikungunya | Phase I | 90 | 2 |
| 12 | Cholera Vaccine | Phase II/III | 312 | 8 |
